|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09688 ZAI LAB
Nominal 
14.120 +0.610 (+4.515%) | 2025/12 - Final USD(K$) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | |
| Net Cash from / (used in) Operating Activities | (150,789) | (214,869) | (198,178) | (367,642) | (549,231) |
| Net Cash from / (used in) Investing Activities | 307,866 | (375,193) | (10,776) | 420,016 | 249,957 |
| Net Cash from / (used in) Financing Activities | 72,353 | 349,889 | (6,433) | (1,730) | 820,202 |
| Increase / (Decrease) in Cash & Cash Equivalents | 229,430 | (240,173) | (215,387) | 50,644 | 520,928 |
| Cash & Cash Equivalents at beginning of period | 550,781 | 791,264 | 1,009,273 | 964,903 | 442,859 |
| Effect of Foreign Exchange Rate Changes | 478 | (310) | (2,622) | (6,274) | 1,116 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 780,689 | 550,781 | 791,264 | 1,009,273 | 964,903 |
| Remarks: | Real time quote last updated: 27/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | USD -175,537 |
| %Change | -31.725% |
| EPS / (LPS) | USD -0.160 |
| NBV Per Share ($) | USD 0.639 |